Congestive Heart Failure (CHF) Treatment Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4164115
- 93 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Congestive Heart Failure (CHF) Treatment Devices market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Congestive Heart Failure (CHF) Treatment Devices market segmented into
Ventricular Assist Devices
Counter Pulsation Devices
Implantable Cardioverter Defibrillators
Other
Based on the end-use, the global Congestive Heart Failure (CHF) Treatment Devices market classified into
Hospitals
Clinics
Others
Based on geography, the global Congestive Heart Failure (CHF) Treatment Devices market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Jarvik Heart
ReliantHeart
Biotronik SE & Co.
Berlin Heart GmbH
St. Jude Medical
Medtronic
Boston Scientific Corporation
Teleflex
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES INDUSTRY
2.1 Summary about Congestive Heart Failure (CHF) Treatment Devices Industry
2.2 Congestive Heart Failure (CHF) Treatment Devices Market Trends
2.2.1 Congestive Heart Failure (CHF) Treatment Devices Production & Consumption Trends
2.2.2 Congestive Heart Failure (CHF) Treatment Devices Demand Structure Trends
2.3 Congestive Heart Failure (CHF) Treatment Devices Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Ventricular Assist Devices
4.2.2 Counter Pulsation Devices
4.2.3 Implantable Cardioverter Defibrillators
4.2.4 Other
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Ventricular Assist Devices
5.2.2 Counter Pulsation Devices
5.2.3 Implantable Cardioverter Defibrillators
5.2.4 Other
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Ventricular Assist Devices
6.2.2 Counter Pulsation Devices
6.2.3 Implantable Cardioverter Defibrillators
6.2.4 Other
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Clinics
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Ventricular Assist Devices
7.2.2 Counter Pulsation Devices
7.2.3 Implantable Cardioverter Defibrillators
7.2.4 Other
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Clinics
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Ventricular Assist Devices
8.2.2 Counter Pulsation Devices
8.2.3 Implantable Cardioverter Defibrillators
8.2.4 Other
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Ventricular Assist Devices
9.2.2 Counter Pulsation Devices
9.2.3 Implantable Cardioverter Defibrillators
9.2.4 Other
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Jarvik Heart
10.1.2 ReliantHeart
10.1.3 Biotronik SE & Co.
10.1.4 Berlin Heart GmbH
10.1.5 St. Jude Medical
10.1.6 Medtronic
10.1.7 Boston Scientific Corporation
10.1.8 Teleflex
10.2 Congestive Heart Failure (CHF) Treatment Devices Sales Date of Major Players (2017-2020e)
10.2.1 Jarvik Heart
10.2.2 ReliantHeart
10.2.3 Biotronik SE & Co.
10.2.4 Berlin Heart GmbH
10.2.5 St. Jude Medical
10.2.6 Medtronic
10.2.7 Boston Scientific Corporation
10.2.8 Teleflex
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Congestive Heart Failure (CHF) Treatment Devices Product Type Overview
2.Table Congestive Heart Failure (CHF) Treatment Devices Product Type Market Share List
3.Table Congestive Heart Failure (CHF) Treatment Devices Product Type of Major Players
4.Table Brief Introduction of Jarvik Heart
5.Table Brief Introduction of ReliantHeart
6.Table Brief Introduction of Biotronik SE & Co.
7.Table Brief Introduction of Berlin Heart GmbH
8.Table Brief Introduction of St. Jude Medical
9.Table Brief Introduction of Medtronic
10.Table Brief Introduction of Boston Scientific Corporation
11.Table Brief Introduction of Teleflex
12.Table Products & Services of Jarvik Heart
13.Table Products & Services of ReliantHeart
14.Table Products & Services of Biotronik SE & Co.
15.Table Products & Services of Berlin Heart GmbH
16.Table Products & Services of St. Jude Medical
17.Table Products & Services of Medtronic
18.Table Products & Services of Boston Scientific Corporation
19.Table Products & Services of Teleflex
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Congestive Heart Failure (CHF) Treatment Devices Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Congestive Heart Failure (CHF) Treatment Devices Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Congestive Heart Failure (CHF) Treatment Devices Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Congestive Heart Failure (CHF) Treatment Devices Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
